Confluence Wealth Services Inc. trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 13.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 673 shares of the medical equipment provider’s stock after selling 101 shares during the quarter. Confluence Wealth Services Inc.’s holdings in Intuitive Surgical were worth $331,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after buying an additional 493,126 shares during the last quarter. Capital World Investors boosted its position in Intuitive Surgical by 1.0% during the 1st quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock worth $2,907,079,000 after acquiring an additional 73,634 shares during the period. American Century Companies Inc. grew its stake in shares of Intuitive Surgical by 3.0% in the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock worth $1,066,837,000 after purchasing an additional 70,556 shares in the last quarter. Clearbridge Investments LLC increased its holdings in shares of Intuitive Surgical by 1.6% during the second quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock valued at $881,380,000 after purchasing an additional 30,449 shares during the period. Finally, Assenagon Asset Management S.A. raised its stake in shares of Intuitive Surgical by 15.4% during the second quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider’s stock valued at $659,893,000 after purchasing an additional 197,841 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.
Intuitive Surgical Stock Up 0.2 %
Intuitive Surgical stock opened at $507.42 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $269.49 and a 12 month high of $523.34. The stock has a market cap of $180.73 billion, a price-to-earnings ratio of 81.58, a price-to-earnings-growth ratio of 4.95 and a beta of 1.39. The business has a 50 day moving average price of $490.97 and a two-hundred day moving average price of $448.54.
Insiders Place Their Bets
Wall Street Analyst Weigh In
A number of analysts have commented on ISRG shares. Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Barclays upped their target price on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Finally, BTIG Research set a $535.00 target price on Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $513.74.
Check Out Our Latest Analysis on Intuitive Surgical
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- How to Find Undervalued Stocks
- Intel: Is Now the Time to Be Brave?Â
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Bank Stocks – Best Bank Stocks to Invest In
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.